Seng G. Lim

Seng G. Lim

Hepatology

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 137 publications

Severe hepatitis B flare and liver failure: current assessment and management.

Severe hepatitis B flare and liver failure: current assessment and management.

Journal: Clinical and molecular hepatology

Published: February 04, 2026

HBx interacts with the host YBX3 protein and up-regulates its expression to mediate efficient Hepatitis B viral replication.

HBx interacts with the host YBX3 protein and up-regulates its expression to mediate efficient Hepatitis B viral replication.

Journal: Frontiers in cellular and infection microbiology

Published: October 25, 2025

Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosis.

Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosis.

Journal: The American journal of gastroenterology

Published: October 13, 2025

Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.

Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.

Journal: The American journal of gastroenterology

Published: October 13, 2025

Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.

Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 25, 2025

Long-Term Effectiveness of Tenofovir Alafenamide Versus Entecavir in Treatment-Naive Chronic Hepatitis B: A Real-World Evidence from the Global Alliance for the Study of Hepatitis B Virus.

Long-Term Effectiveness of Tenofovir Alafenamide Versus Entecavir in Treatment-Naive Chronic Hepatitis B: A Real-World Evidence from the Global Alliance for the Study of Hepatitis B Virus.

Journal: The American journal of gastroenterology

Published: July 11, 2025

HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER).

HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER).

Journal: Gut

Published: July 04, 2025

Time for a globally unified chronic HBV terminology?

Time for a globally unified chronic HBV terminology?

Journal: JHEP reports : innovation in hepatology

Published: May 01, 2025

Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs.

Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs.

Journal: Journal of viral hepatitis

Published: May 01, 2025

Standardising HBV nomenclature: a call to action from the HBV Forum.

Standardising HBV nomenclature: a call to action from the HBV Forum.

Journal: The lancet. Gastroenterology & hepatology

Published: April 29, 2025

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.

Journal: Alimentary pharmacology & therapeutics

Published: February 27, 2025

Differential HCC risk among HBV indeterminate types at baseline and by phase transition.

Differential HCC risk among HBV indeterminate types at baseline and by phase transition.

Journal: Gut

Published: February 07, 2025

Showing 1-12 of 137

Last Updated: 09/26/2026